TWO SIGMA INVESTMENTS, LP - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$150,651
-79.3%
63,835
-44.9%
0.00%
-100.0%
Q2 2023$729,427
-29.4%
115,782
-35.4%
0.00%
-33.3%
Q1 2023$1,033,384
+187.0%
179,096
+410.3%
0.00%
+200.0%
Q4 2022$360,05435,0930.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders